A risk-based preoperative evaluation method and management strategy for removing intrauterine contraceptive devices in postmenopausal women

绝经后妇女取出宫内节育器的基于风险的术前评估方法和管理策略

阅读:1

Abstract

BACKGROUND: A large population of women have intrauterine contractive devices (IUCDs) as a result of China's national family planning policy; this has created a significant economic burden and raised technological challenges related to the safe removal of IUCDs in postmenopausal women. It is very important to develop a risk scoring system for the removal of IUCDs (RSSR-IUCDs) to evaluate the preoperative risk of removal and offer management strategies for postmenopausal women. METHODS: A systematic case retrospective analysis was conducted on 320 enrolled women who underwent IUCD removal surgery. After screening, stratifying high-risk factors, and final multifactor Logistic Stepwise Regression Analysis, a model named RSSR-IUCDs was constructed. It was verified using the Hosmer-Lemeshow test and a Receiver Operating Characteristic (ROC) curve was plotted to further analyze the predictive accuracy of IUCD removal failure. RESULTS: Seven high-risk factors were finally selected, namely duration of menopause, IUCD retention time, a history of uterine surgery, the shape of the IUCD, IUCD position, uterine size, and uterine position. The RSSR-IUCDs was developed and demonstrated goodness of fit (χ(2) = 236.558, P = 0.000). The score range of RSSR-IUCDs (Minimum-Maximum) was 0-40. The ROC curve of RSSR-IUCDs demonstrated that the ideal cutoff value was 20 points and the sensitivity and specificity of an initial failure to remove an IUCD were 69.60% and 95.60%, respectively. CONCLUSIONS: The RSSR-IUCD is a scientific, reasonable, and feasible evaluation system which is expected to become a guiding scoring system in accordance with clinical practice for postmenopausal women before the removal of IUCDs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。